NCT02755857View on ClinicalTrials.gov

Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Neutropenia
Interventions
DRUG

Lozanoc

65 mg

Trial Locations (1)

2010

St Vincent's Hospital, Darlinghurst

All Listed Sponsors
lead

Mayne Pharma International Pty Ltd

INDUSTRY

NCT02755857 - Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis | Biotech Hunter | Biotech Hunter